HomepageBSLN • SWX
add
Basilea Pharmaceutica
Vorige slotkoers
CHF 52,10
Dag-range
CHF 51,10 - CHF 52,20
Jaar-range
CHF 37,50 - CHF 59,70
Beurswaarde
684,69 mln. CHF
Gem. volume
39,83K
Koers/winst
17,48
Dividendrendement
-
Primaire beurs
SWX
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (CHF) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 64,21 mln. | -2,90% |
Bedrijfskosten | 8,93 mln. | 11,90% |
Netto inkomsten | 12,22 mln. | -57,02% |
Netto winstmarge | 19,03 | -55,73% |
Winst per aandeel | — | — |
EBITDA | 14,91 mln. | -44,88% |
Effectief belastingtarief | 7,89% | — |
Balans
Totale activa
Totale passiva
| (CHF) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 159,80 mln. | 32,38% |
Totale activa | 282,00 mln. | 9,40% |
Totale passiva | 154,06 mln. | -12,85% |
Totaal aandelenvermogen | 127,94 mln. | — |
Uitstaande aandelen | 12,29 mln. | — |
Koers-boekwaardeverhouding | 5,00 | — |
Rendement op activa | 12,35% | — |
Rendement op kapitaal | 16,04% | — |
Kasstroom
Nettomutatie in liquide middelen
| (CHF) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 12,22 mln. | -57,02% |
Operationele kasstroom | 19,52 mln. | -30,84% |
Kasstroom uit beleggingen | -1,22 mln. | -92,45% |
Kasstroom uit financiering | -3,48 mln. | -31.513,64% |
Nettomutatie in liquide middelen | 14,81 mln. | -46,24% |
Vrije kasstroom | 9,72 mln. | -45,52% |
Over
Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. Basilea was spun off from F. Hoffmann-La Roche in 2000 and has been listed as an independent company on the Swiss stock exchange since March 2004. The company's subsidiary is Basilea Pharmaceutica International AG, Allschwil, which is also based in Allschwil, Switzerland, and in which the company's operating activities are bundled. Wikipedia
CEO
Opgericht
2000
Website
Werknemers
189
